Vaccine News and Research

Latest Vaccine News and Research

The neutralizing antibody response in mRNA vaccinated and boosted healthcare workers against major circulating SARS-CoV-2 Omicron subvariants

Researchers assessed the duration of the neutralizing antibody responses after SARS-CoV-2 mRNA booster vaccination.

27 Jul 2022

SARS-CoV-2 Omicron BA.5 neutralization in vaccinated individuals

Researchers assessed the duration of SARS-CoV-2 Omicron BA.5 neutralization in SARS-CoV-2 vaccinated persons.

27 Jul 2022

Study estimates prevalence of SARS-CoV-2 omicron breakthrough infections in South Africa

Scientists have described the prevalence of vaccine breakthrough SARS-CoV-2 infection in South Africa during the period of delta and omicron circulation.

27 Jul 2022

To stem the spread of monkeypox, health departments tap into networks of those most at risk

On July 23, the World Health Organization declared monkeypox a public health emergency of international concern.

27 Jul 2022

Nasal spray highly effective against HIV and SARS-CoV-2 in animal models

The intranasal delivery of amph-protein vaccines is a potential approach to elicit a mucosal immune response against many infectious diseases.

26 Jul 2022

Study confirms link between Epstein-Barr virus and multiple sclerosis

Researchers investigate the association between Epstein-Barr virus infection and multiple sclerosis.

26 Jul 2022

Three doses of Novavax vaccine effective against Omicron subvariants

Researchers report that Novavax COVID-19 vaccine triggers robust neutralization against SARS-CoV-2 Omicron subvariants.

26 Jul 2022

Researchers pinpoint multiple zoonotic origins of SARS-CoV-2

In a pair of related studies, published July 26, 2022 online via First Release in Science, researchers at University of California San Diego, with colleagues on four continents, show that the origin of the COVID-19 pandemic in 2019 was at the Huanan Seafood Wholesale Market in Wuhan, China, and resulted from at least two instances of the SARS-CoV-2 virus jumping from live animal hosts to humans working or shopping there.

26 Jul 2022

CDC: Novavax's COVID-19 vaccine can be used as another primary series option for adults

Today, CDC Director Rochelle P. Walensky, M.D., M.P.H., endorsed the CDC Advisory Committee on Immunization Practices' (ACIP) recommendation that Novavax's COVID-19 vaccine be used as another primary series option for adults ages 18 years and older.

26 Jul 2022

How has vaccination shaped the global evolutionary trajectory of SARS-CoV-2?

In a new study, researchers developed a maximum likelihood model to capture severe acute respiratory syndrome coronavirus 2 evolutionary dynamics in multiple geographical regions.

26 Jul 2022

BNT162b2 vaccination induces moderate immunity against Omicron variant in children

Researchers evaluated the effectiveness of the BNT162b2 vaccine against the new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant of concern (VOC) Omicron in five to 11-year-old children.

26 Jul 2022

Scientists explore immune memory of common cold coronaviruses before the SARS-CoV-2 pandemic era

In a new study, researchers assessed the immune memory of common cold coronaviruses (CCCs) three years before the coronavirus disease 2019 (COVID-19) pandemic.

26 Jul 2022

Researchers report ‘hybrid immune damping’ following SARS-CoV-2 Omicron infection

Researchers explore the impact of differential immune imprinting patterns in individuals vaccinated against COVID-19 with a history of prior infection.

25 Jul 2022

Quarantine guidance for Omicron infection

The CDC provides updated guidelines on how the U.S. population can protect themselves and others from the SARS-CoV-2 Omicron variant.

25 Jul 2022

A VSV-based COVID vaccine effective against SARS-CoV-2 variants

A new study discusses the development of recombinant vesicular stomatitis virus COVID-19 vaccines.

25 Jul 2022

Bivalent mRNA vaccine induces powerful antibody response to SARS-CoV-2 Omicron subvariants

Researchers discuss the development and efficacy of a bivalent mRNA vaccine against emerging variants such as BA.2.12.1, BA.4, or BA.5.

25 Jul 2022

Why Omicron is more infectious than other SARS-CoV-2 variants

Researchers describe SARS-CoV-2 Omicron mutations and their impact on neutralization and infectivity.

25 Jul 2022

SARS-CoV-2 oral vaccine candidate found to induce neutralizing mucosal IgA

A new study reported the outcomes of a clinical trial evaluating the oral vaccine candidate against SARS-CoV-2 developed by Vaxart.

25 Jul 2022

Dental health care workers report anxiety and depression symptoms during peaks of the pandemic

The first known U.S. study to evaluate the mental health of frontline dentists and dental hygienists during the pandemic found that dental health care workers report anxiety and depression symptoms during peaks of transmission among the public.

25 Jul 2022

Scientists explore SARS-CoV-2 spike protein and platelet-activating factor

Researchers assessed the association between platelet-activating factor (PAF) and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike (S) protein.

25 Jul 2022

Vaccine News and Research

Latest Vaccine News and Research

The neutralizing antibody response in mRNA vaccinated and boosted healthcare workers against major circulating SARS-CoV-2 Omicron subvariants

SARS-CoV-2 Omicron BA.5 neutralization in vaccinated individuals

Study estimates prevalence of SARS-CoV-2 omicron breakthrough infections in South Africa

To stem the spread of monkeypox, health departments tap into networks of those most at risk

Nasal spray highly effective against HIV and SARS-CoV-2 in animal models

Study confirms link between Epstein-Barr virus and multiple sclerosis

Three doses of Novavax vaccine effective against Omicron subvariants

Researchers pinpoint multiple zoonotic origins of SARS-CoV-2

CDC: Novavax's COVID-19 vaccine can be used as another primary series option for adults

How has vaccination shaped the global evolutionary trajectory of SARS-CoV-2?

BNT162b2 vaccination induces moderate immunity against Omicron variant in children

Scientists explore immune memory of common cold coronaviruses before the SARS-CoV-2 pandemic era

Researchers report ‘hybrid immune damping’ following SARS-CoV-2 Omicron infection

Quarantine guidance for Omicron infection

A VSV-based COVID vaccine effective against SARS-CoV-2 variants

Bivalent mRNA vaccine induces powerful antibody response to SARS-CoV-2 Omicron subvariants

Why Omicron is more infectious than other SARS-CoV-2 variants

SARS-CoV-2 oral vaccine candidate found to induce neutralizing mucosal IgA

Dental health care workers report anxiety and depression symptoms during peaks of the pandemic

Scientists explore SARS-CoV-2 spike protein and platelet-activating factor

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Newsletters you may be interested in